Stocktoria

Oncology Institute, Inc. TOI

Nasdaq · stock · Services-Offices & Clinics of Doctors of Medicine · website · IPO 2020-03-13

Oncology Institute, Inc. statistics & valuation

Market cap$538.9M
P / S1.1×
Net margin-12.1%
FCF margin-5.5%
Net debt$77.4M
Enterprise value USD$616.3M
Earnings yield EBIT/EV-5.9%
Return on capital-38.5%

Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.

Profitability & efficiency

Net margin (%)
-7.60% -5.40% 0.10% -25.60% -16.40% -12.10% 202020212022202320242025
Gross margin (%)
202020212022202320242025
Operating margin (%)
-4.40% -22.60% -32.50% -23.80% -15.30% -7.20% 202020212022202320242025
Return on equity (%)
-51.00% -10.50% 0.10% -145.70% -1801.70% 202020212022202320242025
Shares outstanding
59.1M 73.2M 80.6M 74.1M 75.7M 98.9M 202020212022202320242025
Net debt ($)
$5.7M $0 $80.6M $86.8M $93.1M $77.4M 202020212022202320242025
Share buybacks ($)
202020212022202320242025
Return on assets (%)
-21.80% -5.40% 0.10% -39.70% -37.40% -36.80% 202020212022202320242025
Free cash flow margin (%)
-0.40% -17.50% -26.60% -12.60% -7.70% -5.50% 202020212022202320242025
Debt / equity (×)
0.23× 0.00× 0.65× 1.52× 25.95× 202020212022202320242025
EPS ($)
-$0.24 -$0.16 -$0.21 -$0.92 -$0.71 -$0.54 202020212022202320242025

Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).

Key ratios (by fiscal year)

RatioFY2025FY2024FY2023FY2022FY2021FY2020
Operating margin-7.2%-15.3%-23.8%-32.5%-22.6%-4.4%
Net margin-12.1%-16.4%-25.6%0.1%-5.4%-7.6%
FCF margin-5.5%-7.7%-12.6%-26.6%-17.5%-0.4%
Return on assets-36.8%-37.4%-39.7%0.1%-5.4%-21.8%
Return on equity385.5%-1801.7%-145.7%0.1%-10.5%-51.0%
Debt / equity-4.92×25.95×1.52×0.65×0.00×0.23×
Current ratio1.592.154.124.395.171.04

Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.